Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice-Reference-Cited by-同舟云学术

Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice

Published:2014-11-27 Issue:1 Volume:77 Page:75-99
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Butovsky Oleg¹²,Jedrychowski Mark P.³,Cialic Ron¹,Krasemann Susanne⁴,Murugaiyan Gopal¹,Fanek Zain¹,Greco David J.¹,Wu Pauline M.¹,Doykan Camille E.¹,Kiner Olga¹,Lawson Robert J.⁵,Frosch Matthew P.⁶,Pochet Nathalie⁷,Fatimy Rachid El¹,Krichevsky Anna M.¹,Gygi Steven P.³,Lassmann Hans⁸,Berry James⁵,Cudkowicz Merit E.⁵,Weiner Howard L.¹²

Affiliation:

1. Ann Romney Center for Neurologic Diseases; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School; Boston MA

2. Evergrande Center for Immunologic Diseases; Brigham and Women's Hospital, Harvard Medical School; Boston MA 02112

3. Department of Cell Biology; Harvard Medical School; Boston MA

4. Institute of Neuropathology, University Medical Center Hamburg-Eppendorf; Hamburg Germany

5. Department of Neurology; Massachusetts General Hospital; Neurological Clinical Research Institute, Harvard Medical School; Boston MA

6. Massachusetts General Hospital Alzheimer's Disease Research Center, Harvard University; Boston MA

7. Program in Translational NeuroPsychiatric Genomics; Brigham and Women's Hospital, Harvard Medical School, Broad Institute of Massachusetts Institute of Technology and Harvard; Cambridge MA

8. Center for Brain Research, Medical University of Vienna; Vienna Austria

Funder

National Institutes of Health

U.S. Department of Defense

Amyotrophic Lateral Sclerosis Association

National Multiple Sclerosis Society

The Nancy Davis Foundation for Multiple Sclerosis

Edward N. & Della L. Thome Memorial Foundation

Publisher

Wiley

Subject

Neurology (clinical),Neurology